CEBPA and lung adenocarcinoma: There are several mechanisms proposed which could affect BMI1 expression: A very recent report showed C/EBPα protein contributes to inhibit BMI1 expression, suggesting anti-BMI1 inhibition may provide new therapeutic option for lung adenocarcinoma patients with low C/EBPα and high BMI1 expression [42].